Covalon Technologies Ltd (COV)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Covalon Technologies Ltd (COV) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013168
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月27日
◆ページ数:34
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Covalon Technologies Ltd (Covalon) is a researcher, developer and commercialization of medical devices and healthcare technologies. The company offers advanced wound solutions, infection prevention products and perioperative care products. Covalon offers wound care products such as collagen matrix dressing, collagen matrix dressing with silver, wound contact layer, non-adherent foam dressing and superabsorbent dressing, among others. Its infection prevention products and perioperative care product includes self-adherent silicone dressing with absorbent pad, antimicrobial clear silicone adhesive dressing with chlorhexidine and silver and silicone foley catheter, among others. The company also develops and commercializes proprietary technologies in the areas of advanced wound care, cardiology, urology, vascular access, orthopaedics and surgery, among others. Covalon is headquartered in Mississauga, Ontario, Canada.

Covalon Technologies Ltd (COV) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Covalon Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Covalon Technologies Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Covalon Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Covalon Technologies Ltd, Medical Devices Deals, 2011 to YTD 2017 8
Covalon Technologies Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Covalon Technologies Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Covalon Technologies Enters Into Distribution Agreement With Molnlycke Health Care For SurgiClear And IV Clear 10
Licensing Agreements 12
Covalon Enters into Licensing Agreement with University of Michigan 12
Equity Offering 13
Covalon Tech Raises USD1.7 Million in Private Placement of Units 13
Covalon Tech Raise USD0.6 Million in Private Placement of Shares upon Exercise of Warrants 14
Covalon Tech Raises USD0.8 Million in Private Placement of Shares upon Exercise of Warrants 15
Covalon Technologies Completes Private Placement Of Shares For US$2.5 Million 16
Debt Offering 17
Covalon Technologies Completes Private Placement Of Units For US$0.7 Million 17
Covalon Technologies Ltd – Key Competitors 19
Covalon Technologies Ltd – Key Employees 20
Covalon Technologies Ltd – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Strategy And Business Planning 22
Jun 01, 2016: Covalon Announces Further Expansion in the Middle East 22
Financial Announcements 23
Aug 21, 2017: Covalon Releases Third Quarter Financial Results 23
May 29, 2017: Covalon Releases Second Quarter Financial Results 24
Jan 30, 2017: Covalon Posts Record First Quarter Financial Results 25
Aug 19, 2016: Covalon Announces Third Quarter Financial Results 26
May 30, 2016: Covalon Announces Second Quarter Financial Results 27
Feb 29, 2016: Covalon Announces Strong First Quarter Financial Results 28
Jan 27, 2016: Covalon Announces Annual Financial Results 29
Corporate Communications 30
Nov 14, 2017: US Major General Gale S. Pollock (Ret.) Joins Covalon’s Board of Directors 30
Other Significant Developments 31
Jan 03, 2017: Covalon CEO Provides Update on Anticipated Fiscal 2017 Financial Growth 31
Jun 07, 2016: Covalon Announces Participation in Ontario Government’s Medical Trade Mission to Mexico 33
Appendix 34
Methodology 34
About GlobalData 34
Contact Us 34
Disclaimer 34

List of Tables
Covalon Technologies Ltd, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Covalon Technologies Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Covalon Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Covalon Technologies Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Covalon Technologies Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Covalon Technologies Ltd, Medical Devices Deals, 2011 to YTD 2017 8
Covalon Technologies Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Covalon Technologies Enters Into Distribution Agreement With Molnlycke Health Care For SurgiClear And IV Clear 10
Covalon Enters into Licensing Agreement with University of Michigan 12
Covalon Tech Raises USD1.7 Million in Private Placement of Units 13
Covalon Tech Raise USD0.6 Million in Private Placement of Shares upon Exercise of Warrants 14
Covalon Tech Raises USD0.8 Million in Private Placement of Shares upon Exercise of Warrants 15
Covalon Technologies Completes Private Placement Of Shares For US$2.5 Million 16
Covalon Technologies Completes Private Placement Of Units For US$0.7 Million 17
Covalon Technologies Ltd, Key Competitors 19
Covalon Technologies Ltd, Key Employees 20
Covalon Technologies Ltd, Other Locations 21

★海外企業調査レポート[Covalon Technologies Ltd (COV)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fauji Fertilizer Co Ltd (FFC):企業の財務・戦略的SWOT分析
    Fauji Fertilizer Co Ltd (FFC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • MEDACTA International SA:製品パイプライン分析
    Summary MEDACTA International SA (MEDACTA) is a medical device company that offers orthopedic surgical equipment. The company conducts research, development, manufacturing and commercialization of orthopedic products, neurosurgical systems and instrumentation. It offers prosthetic solutions for hip, …
  • AdvantEdge Healthcare Solutions Inc-医療機器分野:企業M&A・提携分析
    Summary AdvantEdge Healthcare Solutions Inc (AdvantEdge) is a healthcare service provider that offers medical billing, coding and revenue cycle management solutions. The center’s solutions include medical billing, coding, reporting, dashboards and business intelligence, consulting and practice manag …
  • Doxa AB (DOXA):医療機器:M&Aディール及び事業提携情報
    Summary Doxa AB (Doxa) is a medical device company that develops, manufactures and markets dental bioceramic products. The company’s product includes ceramir crown and bridge, which is dental cement for permanent fixtures including ceramic structures with aluminum oxide or zirconia bodies. Its bioma …
  • FirstRand Ltd (FSR):企業の財務・戦略的SWOT分析
    FirstRand Ltd (FSR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Delaware Electric Cooperative Inc:企業の戦略的SWOT分析
    Delaware Electric Cooperative Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major p …
  • GP Pharm SA:製薬・医療:M&Aディール及び事業提携情報
    Summary GP Pharm SA (GP Pharm) is a biopharmaceutical company that develops and markets injectables in the areas of oncology and urology. The company provides product portfolio such as injectable dosage forms for the treatment of advanced prostate cancer; nocturnal enuresis and central diabetes insi …
  • Nomura Research Institute Ltd (4307):企業の財務・戦略的SWOT分析
    Nomura Research Institute Ltd (4307) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Ilmarinen Mutual Pension Insurance Co-エネルギー分野:企業M&A・提携分析
    Summary Ilmarinen Mutual Pension Insurance Company (IMPIC) is a financial service provider that offers pension insurance and related services. The company provides services for private customers, which include information on pensions, retiring, pensioner, forms and brochures, pensioner's tax card, a …
  • Fingrid Oyj:発電所・企業SWOT分析
    Fingrid Oyj - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees (execut …
  • Curadev Pharma Pvt Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Curadev Pharma Pvt Ltd (Curadev Pharma) is a small molecule drug discovery company that manufactures, discovers, and delivers formulations. The company manufactures formulations and APIs such as cyclodextrin in collaboration with the University of Greenwich and creates and out-licenses pre-I …
  • Black Hills Corporation:発電所・企業SWOT分析
    Black Hills Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key emplo …
  • Herstal SA:企業の戦略・SWOT・財務情報
    Herstal SA - Strategy, SWOT and Corporate Finance Report Summary Herstal SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • PT Bank Bukopin Tbk:企業の戦略・SWOT・財務分析
    PT Bank Bukopin Tbk - Strategy, SWOT and Corporate Finance Report Summary PT Bank Bukopin Tbk - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Qantas Airways Limited:企業の戦略・SWOT・財務分析
    Qantas Airways Limited - Strategy, SWOT and Corporate Finance Report Summary Qantas Airways Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • ViroGates AS (VIRO):医療機器:M&Aディール及び事業提携情報
    Summary ViroGates AS (ViroGates) is a meditech company that offers prognostic products. The company develops a prognostic biomarker to make the suPAR test presented as a commercially available test. Its products comprise measures suPAR, quick triage and ELISA. ViroGates’ suparnostic products offer a …
  • Interprotein Corp-製薬・医療分野:企業M&A・提携分析
    Summary Interprotein Corp (Interprotein) is a drug discovery company that conducts research and develops small molecule drugs. The company provides IL-6 inhibitor, IgE inhibitor, notch1 inhibitor, tubulin polymerization inhibitors, TIM-3 inhibitor, NKG2A, HLA-E and CD94 inhibitor; KIR and HLA-C inhi …
  • Tsumura & co (4540):企業の財務・戦略的SWOT分析
    Tsumura & co (4540) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Covalon Technologies Ltd (COV):企業の財務・戦略的SWOT分析
    Summary Covalon Technologies Ltd (Covalon) is a researcher, developer and commercializer of medical products and healthcare technologies. The company offers advanced wound care, infection prevention and perioperative care products. Its wound care products include collagen matrix dressing, collagen m …
  • Deutsche Telekom AG:戦略・SWOT・企業財務分析
    Deutsche Telekom AG - Strategy, SWOT and Corporate Finance Report Summary Deutsche Telekom AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆